跳至主要内容
临床试验/CTRI/2024/03/063683
CTRI/2024/03/063683已完成不适用

Effectiveness of preoperative Olanzapine versus Placebo, as an add on drug, on the incidence of postoperative nausea and vomiting in laparoscopic gynecological surgeries: a stratified randomised control trial

Dr Prasanta Kumar Das1 个研究点 分布在 1 个国家目标入组 112 人开始时间: 2024年3月18日最近更新:

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
112
试验地点
1
主要终点
To compare the incidence of PONV in first 24 hours after surgery between two groups

研究概览

简要总结

Postoperative nausea and vomiting (PONV) is the most distressing event after laparoscopic gynecological surgeries. There have been studies showing the incidence is still nearly 40% even after using dual prophylactic measures. Olanzapine has been effective in reducing PONV in chemotherapy induced nausea and vomiting. In this study we hypothesize that administering preoperative oral Olanzapine in addition to intraoperative ondansetron and dexamethasone would further reduce the incidence of PONV.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
Participant and Investigator Blinded

入排标准

年龄范围
18.00 Year(s) 至 65.00 Year(s)(—)
性别
Female

入选标准

  • Gynecological patients undergoing laparoscopic surgeries ASA 1 and 2.

排除标准

  • no consent, allergic to study drugs, renal and hepatic failure, on antiemetic and antipsychotic medications, prolonged qt interval, history of obstructive sleep apnea.

结局指标

主要结局

To compare the incidence of PONV in first 24 hours after surgery between two groups

时间窗: To compare the incidence of PONV in first 24 hours after surgery between two groups

次要结局

  • severity of nausea and vomting by 4- point severity scale(over 24 hours)
  • requirement of rescue antiemetic (inj.Metoclopramide 10mg IV)(12 hours)
  • Quality of recovery(QoR - 15)(over 24 hours)
  • Side effects of Olanzapine(over 24 hours)

研究者

发起方
Dr Prasanta Kumar Das
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr Nirmala Phobba

AIIMS BHUBANESWAR

研究点 (1)

Loading locations...

相似试验